Dataset and cohort used in the cited comparison. Dataset population counts do not establish successful prediction coverage.
These checks assess whether the evidence supports a reproducible investigation. A source-checked score alone does not meet these requirements.
Release 2026-09-29-06401fd5b220 · Evidence verified: Not verified
Exact outcomes, predictions, identifiers and evaluator are connected.
Missing or unresolved evidence
Verified: Not verified
Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.
Missing or unresolved evidence
Verified: Not verified
A pinned recipe describes the inputs, environment and resource requirements.
Missing or unresolved evidence
Verified: Not verified
Separate data and exposure records support an independent test.
Missing or unresolved evidence
Verified: Not verified
Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.
No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.
3 evaluations · 21 results. Different protocols are not a single leaderboard.
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.85 ± 0.036 AUPRC fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.036 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column AUPRC; XML row3 column7 |
| Configuration: Combined | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.85 ± 0.021 MCC dimensionless · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.021 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column MCC; XML row4 column6 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.94 AUROC fraction · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column AUROC; XML row2 column8 |
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.98 ± 0.004 Specificity fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.004 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Specificity; XML row3 column4 |
| Configuration: Combined | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.99 ± 0.004 Specificity fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.004 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Specificity; XML row4 column4 |
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.75 ± 0.063 Sensitivity fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.063 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Sensitivity; XML row3 column3 |
| Configuration: Combined | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.97 ± 0.004 Weighted F1 fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.004 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Weighted F1; XML row4 column5 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.96 ± 0.008 Weighted F1 fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.008 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Weighted F1; XML row2 column5 |
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.96 ± 0.005 Val Accuracy fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.005 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Val Accuracy; XML row3 column2 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.78 ± 0.046 MCC dimensionless · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.046 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column MCC; XML row2 column6 |
| Configuration: Combined | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.97 ± 0.004 Val Accuracy fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.004 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Val Accuracy; XML row4 column2 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.84 ± 0.049 AUPRC fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.049 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column AUPRC; XML row2 column7 |
| Configuration: Combined | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.92 ± 0.013 AUPRC fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.013 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column AUPRC; XML row4 column7 |
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.77 ± 0.043 MCC dimensionless · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.043 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column MCC; XML row3 column6 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.74 ± 0.071 Sensitivity fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.071 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Sensitivity; XML row2 column3 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.96 ± 0.008 Val Accuracy fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.008 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Val Accuracy; XML row2 column2 |
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.94 AUROC fraction · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column AUROC; XML row3 column8 |
| Configuration: Combined | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.83 ± 0.045 Sensitivity fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.045 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Sensitivity; XML row4 column3 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.99 ± 0.004 Specificity fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.004 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Specificity; XML row2 column4 |
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.96 ± 0.007 Weighted F1 fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.007 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Weighted F1; XML row3 column5 |
| Configuration: Combined | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.97 AUROC fraction · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column AUROC; XML row4 column8 |
Source checking is not independent reproduction. Release 2026-09-29-06401fd5b220.
A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
6 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| attributes.reported_population Not reported Context-only references | Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Table 1.: Val Accuracy, Protective-antigen classification feature comparison Version: preprint version in PMC | missing or unspecified No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Exact retrieved primary paper artifact bytes. |
| attributes.source_locator Table 1.: Val Accuracy, Protective-antigen classification feature comparison Context-only references | Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Table 1.: Val Accuracy, Protective-antigen classification feature comparison Version: preprint version in PMC | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Exact retrieved primary paper artifact bytes. |
| attributes.split 372 protection-positive and 3,720 protection-negative samples. Context-only references | Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Table 1.: Val Accuracy, Protective-antigen classification feature comparison Version: preprint version in PMC | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Exact retrieved primary paper artifact bytes. |
| attributes.subset Protective-antigen classification feature comparison Context-only references | Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Table 1.: Val Accuracy, Protective-antigen classification feature comparison Version: preprint version in PMC | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Exact retrieved primary paper artifact bytes. |
| description Dataset and cohort used in the cited comparison. Dataset population counts do not establish successful prediction coverage. Context-only references | Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Table 1.: Val Accuracy, Protective-antigen classification feature comparison Version: preprint version in PMC | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Exact retrieved primary paper artifact bytes. |
| name Protective-antigen classification feature comparison Context-only references | Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Table 1.: Val Accuracy, Protective-antigen classification feature comparison Version: preprint version in PMC | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Exact retrieved primary paper artifact bytes. |
View linked audit checks and correction history
Release 2026-09-29-06401fd5b220 · Record review: needs review
Stable ID: paper-dataset-c1edd1f6f7e93d9f6e